0001415889-21-000326.txt : 20210115 0001415889-21-000326.hdr.sgml : 20210115 20210115171511 ACCESSION NUMBER: 0001415889-21-000326 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210113 FILED AS OF DATE: 20210115 DATE AS OF CHANGE: 20210115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cable Thomas J. CENTRAL INDEX KEY: 0001472158 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34475 FILM NUMBER: 21533005 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OMEROS CORP CENTRAL INDEX KEY: 0001285819 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911663741 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-676-5000 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 4 1 form4-01152021_050101.xml X0306 4 2021-01-13 0001285819 OMEROS CORP OMER 0001472158 Cable Thomas J. C/O OMEROS CORPORATION 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 true false false false Common Stock 2021-01-13 4 M 0 5000 4.53 A 40067 D Common Stock 2021-01-13 4 S 0 5000 16.97 D 35067 D Stock Option (Right to Buy) 4.53 2021-01-13 4 M 0 5000 0 D 2012-05-31 2021-05-26 Common Stock 5000 0 D Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This transaction was executed in multiple trades at prices ranging from $16.45 to $17.47; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. /s/ Peter B. Cancelmo, Attorney-in-Fact 2021-01-15